Article and Video CATEGORIES
GRACE is very happy to bring to you more videos from our program, Supportive Care in Cancer Treatment.
In this video our host, Dr. Arjun Gupta speaks with Shaalan Beg, MD, with UT Southwestern Medical Center in Dallas, TX . Dr. Beg and Dr. Gupta discuss Malignant Ascites, or fluid in the belly, in patients with cancer.
Ascites is the fluid that can accumulate within the peritoneal cavity. Cancers of the colon/rectum, ovary, breast, lung, pancreas, liver and lymphoma are generally the most common cancers that may develop ascites.
For further information, Drs. Gupta and Beg have recently also published a patient page in JAMA Oncology - you can view the patient page here:
https://jamanetwork.com/
A huge thankyou to our sponsors who have made this series possible!
To join the conversation, visit https://cancergrace.org/forum.
To find additional CancerGRACE resources, visit https://cancergrace.org.
To donate to CancerGRACE, visit https://cancergrace.org/donate.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...
Hi Bluebird, Welcome to GRACE. I'm sorry you're going through this scare and hope it's just inflammation or from an infection you didn't know you had.
A CT would be...
Radiation + Brain Operation has just been discarded due to high risk. They will double Tagrisso dosis and then wait to see if it works, then try traditional Chemo. I would...
Hi and welcome to GRACE. I'm sorry to know you are entering a new stage. I'm not about to comment just now but wanted to let you know I see your...
Edit to say, we can't give advice but we can comment with views and facts. :)
My first thought is to ask if she has been seen at a large...
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...